IDH2 and myelodysplastic syndrome: Patients with myelodysplastic syndrome (MDS) who have TET2/IDH mutations have been found to show a distinct phenotype in their natural killer (NK) cells (22). This suggests that these mutations are present in NK cells and are associated with changes in both phenotype and function (22).